Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Oncology Letters|May 8, 2018
Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cellsJun-Wei Gai, Wasilijiang Wahafu, Liming Song, et al.
Current Urology|March 20, 2024
Prognostic value of Controlling Nutritional Status score for postoperative complications and biochemical recurrence in prostate cancer patients undergoing laparoscopic radical prostatectomyTianyu Xiong, Xiaobo Ye, Guangyi Zhu, et al.
Translational Andrology and Urology|June 23, 2021
Impact of preoperative body mass index on perioperative outcomes is optimized by enhanced recovery protocols in laparoscopic radical cystectomy with intracorporeal urinary diversionHouyi Wei, Jiandong Gao, Mingshuai Wang, et al.
BMC Urology|November 18, 2019
The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching studyWasilijiang Wahafu, Sai Liu, Wenbin Xu, et al.
Molecular Biomedicine|May 15, 2026
Superparamagnetic iron oxide nanoparticle-driven 3-aroyl-1,4-diarylpyrrole nanocomposites (ARDAP@SPION-PEI) mediate renal cancer cell PANoptosis by regulating chromatin accessibilityHongliang Shen, Zeyu Cui, Yilun Wu, et al.
Bladder (San Francisco, Calif.)|September 11, 2025
Diagnostic value of preoperative computed tomography-urography combined with inflammatory markers in predicting lymph node metastasis in patients undergoing radical cystectomyKun Yang, Mingxin Jiang, Tianyu Zhang, et al.
ACS Applied Materials & Interfaces|September 5, 2025
Cu-Mn Bimetallic Mesoporous Silica Nanosonosensitizers Enable Oxeiptosis-Mediated Sonodynamic Therapy for Ultra-Minimally Invasive Treatment of Benign Prostatic HyperplasiaMingyu Chang, Jingcheng Lv, Lianhui Sun, et al.
European Journal of Cancer (Oxford, England : 1990)|May 21, 2024
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinomaWang Qu, Cheng Fu, Weiqing Han, et al.
Pageof 4